We are live on ! Find out more
TAM

Tiverton Asset Management Portfolio holdings

AUM $2.88B
1-Year Est. Return 5.6%
This Fund
S&P 500
This Quarter Est. Return
-13.82%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.83%
5 Year Est. Return
+105.31%
10 Year Est. Return
AUM
$1.66B
AUM Growth
-$371M
Cap. Flow
-$74.3M
Cap. Flow %
-4.47%
Top 10 Hldgs %
36.06%
Holding
527
New
118
Increased
122
Reduced
98
Closed
37

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$14.9M
2
CI icon
Cigna
CI
+$14.2M
3
UNP icon
Union Pacific
UNP
+$9.85M
4
LIN icon
Linde
LIN
+$7.69M
5
AAPL icon
Apple
AAPL
+$5.99M

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Healthcare 16.28%
3 Consumer Discretionary 12.55%
4 Financials 10.59%
5 Communication Services 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDGL icon
476
Madrigal Pharmaceuticals
MDGL
$11.8B
$28K ﹤0.01%
+250
New +$38.7K
ARRY
477
DELISTED
Array Biopharma Inc
ARRY
$28K ﹤0.01%
+1,967
New +$29.8K
BPY
478
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$27K ﹤0.01%
1,656
KIM icon
479
Kimco Realty
KIM
$16.4B
$25K ﹤0.01%
1,716
ALNA
480
DELISTED
Allena Pharmaceuticals
ALNA
$24K ﹤0.01%
+4,414
New +$38.1K
BKNG icon
481
Booking.com
BKNG
$161B
$22K ﹤0.01%
325
WBD icon
482
Warner Bros
WBD
$67.1B
$18K ﹤0.01%
+750
New +$22.8K
XLB icon
483
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
$18K ﹤0.01%
710
-1,018
-59% -$27.1K
NWS icon
484
News Corp Class B
NWS
$17.5B
$16K ﹤0.01%
+1,362
New +$17.8K
PTGX icon
485
Protagonist Therapeutics
PTGX
$9.44B
$15K ﹤0.01%
+2,193
New +$17.4K
SRRK icon
486
Scholar Rock
SRRK
$6.44B
$15K ﹤0.01%
+651
New +$14.7K
TPST icon
487
Tempest Therapeutics
TPST
$14.6M
$13K ﹤0.01%
8
+5
+167% +$10.3K
ARVN icon
488
Arvinas
ARVN
$572M
$12K ﹤0.01%
+933
New +$14.8K
PTE
489
DELISTED
PolarityTE, Inc. Common Stock
PTE
$12K ﹤0.01%
+36
New +$13K
EIGR
490
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$10K ﹤0.01%
+31
New +$10K
ADSK icon
491
Autodesk
ADSK
$52.6B
-3,634
Closed -$567K
BFH icon
492
Bread Financial
BFH
$4.38B
-1,159
Closed -$219K
BIIB icon
493
Biogen
BIIB
$30.7B
-2,010
Closed -$710K
BILI icon
494
Bilibili
BILI
$7.84B
-25,506
Closed -$344K
BLUE
495
DELISTED
bluebird bio
BLUE
-884
Closed -$1.67M
CDNS icon
496
Cadence Design Systems
CDNS
$93.4B
-4,605
Closed -$209K
CLX icon
497
Clorox
CLX
$12.7B
-1,608
Closed -$242K
CNI icon
498
Canadian National Railway
CNI
$76.6B
-1,074
Closed -$96K
DVAX
499
DELISTED
Dynavax Technologies
DVAX
-12,080
Closed -$150K
FIS icon
500
Fidelity National Information Services
FIS
$22.1B
-5,934
Closed -$647K

Similar funds

Tiverton Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Tiverton Asset Management held 527 positions worth $1.66B, down 18% from $2.04B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tiverton Asset Management withdrew a net $74.3M in Q4 2018, closing 37 positions and reducing 98 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $25M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tiverton Asset Management opened a new position in Linde worth $7.59M.

  • Tiverton Asset Management's largest Q4 2018 buy was Linde: 48,645 shares worth $7.59M.
  • Tiverton Asset Management added most to Amazon in Q4 2018, an estimated $14.9M increase.
  • Tiverton Asset Management's biggest Q4 2018 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $72.5M.
  • Tiverton Asset Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $25M.
  • Tiverton Asset Management's ten largest holdings make up 36% of its $1.66B portfolio in Q4 2018.
  • Tiverton Asset Management opened 118 new positions and closed 37 in Q4 2018.
  • Tiverton Asset Management's portfolio value fell 18% quarter-over-quarter to $1.66B.

Based on Tiverton Asset Management's 13F filing for Q4 2018, filed 13 Feb 2019.